Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Find out which rewards program is best suited for your lifestyle and spending habits. Maximize your value with our expert insights!
22,671 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A worrying trend shows high school students taking on large loans to pursue trades that pay modest starting wages. Th...
As Social Security nears a 2033 funding cliff, the politics of protection clash with actuarial reality. Markets and r...
Financial recovery goes hand in hand with personal recovery. This guide shows how to budget for treatment, tackle deb...
Elon Musk unveiled Terafab, a high-profile joint venture with Intel to build the world’s largest chip plant, aiming f...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A much-anticipated Las Vegas weekend fundraiser tied to Flavor Flav has people buzzing. But the real story isn’t the ...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
As retirement checks begin, a rising share of households worry about debts that survive into retirement. The IRS can ...
Burger King is piloting OpenAI-powered headsets in 500 U.S. locations to boost efficiency and coaching. The program c...
The NHL and CFTC have agreed to study licensed, crypto-backed sports prediction markets under a new memorandum of und...
Singapore’s Class of 2026 faces a tough start: government-backed GRIT traineeships pay far less than typical first-pa...